(Aug 28): It is said that Dr Ang Peng Tiam has not taken a lunch break in years. The renowned oncologist, his reputation burnished as the lead doctor who treated Prime Minister Lee Hsien Loong during his illness in the early 1990s, regularly attended to a waiting room bursting at the seams with patients through to the afternoon.

Dr Ang is also CEO of TalkMed Group, which specialises in treatment and palliative care for people suffering from cancer. It has 13 doctors operating out of eight clinics at private hospitals here. For FY2016, TalkMed reported a 5% increase in revenue to $68.9 million and a 0.2% rise in earnings to $37.4 million. This financial performance might seem quite pedestrian, but shares in TalkMed hit a high of $0.95 in late April, valuing the whole company at some $1.2 billion, or 33 times its FY2016 earnings.

On June 27, following protracted proceedings, Dr Ang was suspended by the Singapore Medical Council (SMC) for eight months for professional misconduct. Analysts estimate that he brings in as much as 60% of the company’s revenue. Since news of his suspension broke, shares in TalkMed have slid 17%. Yet, the stock is still up 20% since the beginning of the year and trading at 23 times the company’s FY2016 earnings.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook